Figure 1 miRNA regulate estrogen production mediated by aromatase enzyme activity, and ERa mediated transcriptional activity, co-regulatory proteins and signaling pathways.
miRNA | Target | Function | Ref. |
miR-27a | ZBTB10 | Hormone response | 38 |
miR-18a, -19b, -20b |
p160 and AIBI | E2 response | 33 |
miR-193b | AKR1C2 | E2 production | 44 |
miR-21,-15a,-16, -342 |
Bcl-2 and PTEN | TAM response | 39, 40 |
miR-221/222, -206 | β-catenin | Fulvestrant resistance | 50 |
miR-128a | TGFβ-R1 | Aromatase inhibitors resistance | 54 |
miR-23b,-24-1, -27b, -29a |
ESR1 | Dicer activity | 47 |
miR-375 | RASD1 | Tumor progression | 36 |
miR-145 | TP53 | Growth inhibition | 42 |
miR-22,-191/425 cluster | ERα | Tumorigenesis | 43, 31 |
miR-17-9p | AIB1 and c-Myc | Metastasis | 41 |
miR-125a | ERBB2 | HER2 expression | 59 |
miR-101 | Akt | Cell survival | 29 |
miR-17-92 | c-Myc | Promote transcription | 35 |
miR-206, -34a | ERα | Proliferation | 37, 32 |
miR-200c | ZEB1/2, Trk/Bmi1 |
BRCA-1 | 55 |
miR-182 | BRCA-1 | DNA repair | 56 |
Table 1: Lists of miRNA, whose expression regulates drug resistance, transcriptional factors, and other co-regulatory proteins involve in breast cancer metastasis